Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Somatic PHF6 Mutations In Myeloid Malignancies

Wenyi Shen, MD, Bartlomiej P Przychodzen, PhD, Chantana Polprasert, MD, Naoko Hosono, MD, PhD, Brittney Dienes, Satoru Miyano, PhD, Yuichi Shiraishi, PhD, Kenichi Yoshida, MD, Seishi Ogawa, MD, PhD, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD, Hideki Makishima, MD, PhD

Blood (2013) 122 (21): 2514.

https://doi.org/10.1182/blood.V122.21.2514.2514

Published: 2013

Journal Articles

Spliceosome Mutations Are Frequent In Patients With Myelodysplastic Syndromes Who Failed Hypomethylating Therapy: Possible Implications Of Spliceosome Inhibitors As Alternative Treatments

Valeria Visconte, PhD, Fabiola Traina, MD, PhD, Ali Tabarroki, MD, Edy Hasrouni, Jing Ai, MD, PhD, Matt Kalaycio, MD, Anjali S. Advani, MD, Hien K. Duong, MD, Yogen Saunthararajah, M.D., John Barnard, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 5237.

https://doi.org/10.1182/blood.V122.21.5237.5237

Published: 2013

Journal Articles

LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia

Ramon V. Tiu, MD, Valeria Visconte, PhD, Paul Elson, Michael J. Clemente, Ali Tabarroki, MD, Edy Hasrouni, Amy Porter, Lindsey Mooney, Manuel G. Afable, II, Ricki Englehaupt, Joy Juersivich, RN, MSc, Kathleen Cooper, RN, MSc, Mikkael A. Sekeres, MD, MS, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2013) 122 (21): 3711.

https://doi.org/10.1182/blood.V122.21.3711.3711

Published: 2013

Journal Articles

A Specific Mechanism By Which NPM1 mutations Impede Myeloid Differentiation Also Explains The Link With DNMT3A Mutation

Xiaorong Gu, PhD, Reda Z Mahfouz, MD/PhD, Francis Enane, MS, Zhenbo Hu, MD, PhD, Michael J. Clemente, Bartlomiej P Przychodzen, PhD, Mikkael A. Sekeres, MD, MS, Anjali S. Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Yogen Saunthararajah, M.D.

Blood (2013) 122 (21): 1254.

https://doi.org/10.1182/blood.V122.21.1254.1254

Published: 2013

Journal Articles

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, John Desamito, Hien K. Duong, MD, Alan E. Lichtin, Anjali S. Advani, MD, Ronald M. Sobecks, MD, Tracy Cinalli, RN, Kristin Dodd, RN, Jing Ai, MD, PhD, Yogen Saunthararajah, M.D., Matt Kalaycio, MD, Brady L. Stein, MD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 1586.

https://doi.org/10.1182/blood.V122.21.1586.1586

Published: 2013

Journal Articles

Molecular Characterization Of Myeloid Neoplasms Harboring Isochromosome 17q Abnormality

Valeria Visconte, PhD, Ali Tabarroki, MD, Li Zhang, Edy Hasrouni, Chris Gerace, Robyn Frum, Anjali S. Advani, MD, Hien K. Duong, MD, Matt Kalaycio, MD, Yogen Saunthararajah, M.D., Mikkael A. Sekeres, MD, MS, Eric D. Hsi, MD, Shashirekha Shetty, PhD, Heesun J. Rogers, MD, PhD, Ramon V. Tiu, MD

Blood (2013) 122 (21): 2596.

https://doi.org/10.1182/blood.V122.21.2596.2596

Published: 2013

Journal Articles

Splicing Factor 3b Subunit 1 (SF3B1) Heterozygous Mice Manifest a Hematologic Phenotype Similar To Low Risk Myelodysplastic Syndromes With Ring Sideroblasts

Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, Ali Tabarroki, MD, Li Zhang, Yvonne Parker, Edy Hasrouni, Reda Z Mahfouz, MD/PhD, Quteba Ebrahem, MD, Kyoichi Isono, Haruhiko Koseki, Anjali S. Advani, MD, Yogen Saunthararajah, M.D., Mikkael A. Sekeres, MD, MS, Daniel Lindner, John Barnard, Ramon V. Tiu, MD

Blood (2013) 122 (21): 259.

https://doi.org/10.1182/blood.V122.21.259.259

Published: 2013

Journal Articles

Gender Is A Major Determinant of Cytidine Analogue Metabolism and May Contribute to Differences in Treatment Outcomes

Reda Z Mahfouz, MD, Ania Jankowska, PhD, Quteba Ebrahem, MD, Zhenbo Hu, MD, Kenneth K. Chan, Ph.D, Donald Lavelle, Ph.D., Joseph DeSimone, PhD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD, BS, Jaroslaw P. Maciejewski, MD, PhD, Yogen Saunthararajah, M.D.

Blood (2011) 118 (21): 1434.

https://doi.org/10.1182/blood.V118.21.1434.1434

Published: 2011

Journal Articles

The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).

Mikkael A. Sekeres, MD, MS, Alex Z Fu, PhD, Marc Earl, PharmD, Matt Kalaycio, MD, Anjali Advani, MD, Yogen Saunthararajah, M.D., Ronald Sobecks, MD, Edward Copelan, MD

Blood (2009) 114 (22): 1043.

https://doi.org/10.1182/blood.V114.22.1043.1043

Published: 2009

Journal Articles

Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).

Anna K Brady, BS, BA, Alex Z Fu, PhD, Marc Earl, PharmD, Matt Kalaycio, Anjali Advani, MD, Yogen Saunthararajah, M.D., Ronald Sobecks, Edward Copelan, MD, Mikkael A. Sekeres, MD, MS

Blood (2009) 114 (22): 1012.

https://doi.org/10.1182/blood.V114.22.1012.1012

Published: 2009

Journal Articles

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Mazyar Shadman, MD, MPH, Sarah Gibson, MD, Claudiu Cotta, MD, PhD, Eric D. Hsi, MD, Edward Copelan, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Yogen Saunthararajah, M.D., Meagan Effinger, B.A., Anjali Advani, MD

Blood (2009) 114 (22): 4681.

https://doi.org/10.1182/blood.V114.22.4681.4681

Published: 2009

Journal Articles

Whole Epigenome Pattern Characterization in CMML and Related Monocytoid Malignancies.

Rebecca D Ganetzky, B.A., Anna M. Jankowska, MSc, Courtney Prince, B.S., Mikkael A. Sekeres, MD, MS, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 599.

https://doi.org/10.1182/blood.V114.22.599.599

Published: 2009

Journal Articles

TET2 Mutation Status Is Associated with Distinct Hypermethylation Patterns; a Marker of Epigenetic Instability?.

Rebecca D Ganetzky, B.A., Anna M. Jankowska, MSc, Courtney Prince, B.S., Anjali Advani, M.D., Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 215.

https://doi.org/10.1182/blood.V114.22.215.215

Published: 2009

Journal Articles

Differences Between Normal and Leukemic Stem Cell-Specific Methylome Indicates Aberrantly Silenced Genes Involved in the Pathogenesis of Malignant Evolution

Rebecca D Ganetzky, B.A., Ying Jiang, M.D., Ph.D., Jeffrey Falk, Ph.D., Mingjie Jin, Ph.D., Dongyan Liu, M.S., Soledad Negrotto, Ph.D., Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2008) 112 (11): 599.

https://doi.org/10.1182/blood.V112.11.599.599

Published: 2008

Journal Articles

Establishment of Myelodysplastic Syndrome-Specific Methylome: Implications for the Pathogenesis of Clonal Evolution and Association with Survival

Rrebecca D ganetzky, B.A., Ying Jiang, M.D., Ph.D., Courtney Prince, B.S., Mikkael A. Sekeres, MD, MS, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD

Blood (2008) 112 (11): 850.

https://doi.org/10.1182/blood.V112.11.850.850

Published: 2008

NARROW

Somatic PHF6 Mutations In Myeloid Malignancies

Spliceosome Mutations Are Frequent In Patients With Myelodysplastic Syndromes Who Failed Hypomethylating Therapy: Possible Implications Of Spliceosome Inhibitors As Alternative Treatments

LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia

A Specific Mechanism By Which NPM1 mutations Impede Myeloid Differentiation Also Explains The Link With DNMT3A Mutation

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Molecular Characterization Of Myeloid Neoplasms Harboring Isochromosome 17q Abnormality

Splicing Factor 3b Subunit 1 (SF3B1) Heterozygous Mice Manifest a Hematologic Phenotype Similar To Low Risk Myelodysplastic Syndromes With Ring Sideroblasts

Gender Is A Major Determinant of Cytidine Analogue Metabolism and May Contribute to Differences in Treatment Outcomes

The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).

Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).

Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML).

Whole Epigenome Pattern Characterization in CMML and Related Monocytoid Malignancies.

TET2 Mutation Status Is Associated with Distinct Hypermethylation Patterns; a Marker of Epigenetic Instability?.

Differences Between Normal and Leukemic Stem Cell-Specific Methylome Indicates Aberrantly Silenced Genes Involved in the Pathogenesis of Malignant Evolution

Establishment of Myelodysplastic Syndrome-Specific Methylome: Implications for the Pathogenesis of Clonal Evolution and Association with Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only